DE
EW icon

DV Equities’s Edwards Lifesciences EW Stock Holding History

DV Equities’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$69.5K Buy
+815
New +$66.9K 0.01% 291

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

DV Equities's EW Position: Q4 2025 in Review

DV Equities opened a new position in Edwards Lifesciences (EW) in Q4 2025: 815 shares worth $69.5K. The stake represents 0.01% of the portfolio and ranks #291 among its holdings.

1,315 funds tracked by Wall St. Rank hold EW as of Q4 2025.

  • DV Equities held 815 shares of Edwards Lifesciences worth $69.5K as of Q4 2025.
  • Edwards Lifesciences was a new DV Equities position in Q4 2025.
  • Edwards Lifesciences made up 0.01% of DV Equities's portfolio in Q4 2025, its #291 holding.
  • 1,315 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on DV Equities's 13F filing for Q4 2025, filed 17 Feb 2026.